These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19579086)

  • 1. Diabetes mellitus is associated with increased ex vivo-platelet aggregation and decreased response to aspirin - antithrombotic potential of ACE-inhibitors and AT1-antagonists.
    Skowasch D; Tuleta I; Viktor A; Bauriedel G; Nickenig G
    Platelets; 2009 Aug; 20(5):358-9. PubMed ID: 19579086
    [No Abstract]   [Full Text] [Related]  

  • 2. [Decreased platelet aggregation during angiotensin-converting enzyme inhibitor therapy. Results of a pilot study].
    Skowasch D; Lentini S; Andrié R; Jabs A; Bauriedel G
    Dtsch Med Wochenschr; 2001 Jun; 126(24):707-11. PubMed ID: 11446026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of low-density lipoprotein cholesterol and triglycerides and suboptimal glycemic control predict diminished ex vivo aspirin responsiveness in patients with Type 2 diabetes.
    Hovens MM; Snoep JD; Groeneveld Y; Tamsma JT; Eikenboom JC; Huisman MV
    J Thromb Haemost; 2007 Jul; 5(7):1562-4. PubMed ID: 17456193
    [No Abstract]   [Full Text] [Related]  

  • 4. Further ex vivo evidence supporting higher aspirin dosing in patients with coronary artery disease and diabetes.
    Bliden KP; Tantry US; DiChiara J; Gurbel PA
    Circ Cardiovasc Interv; 2011 Apr; 4(2):118-20. PubMed ID: 21505165
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aspirin-ACE inhibitors interaction: myth or reality?].
    Meune C; Mourad JJ
    J Mal Vasc; 2001 Dec; 26(5):284-6. PubMed ID: 11917659
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment.
    Mathewkutty S; McGuire DK
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):541-9. PubMed ID: 19419262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interactions between ACE-inhibitors and aspirin].
    Urbinati S
    Ital Heart J Suppl; 2000 Dec; 1(12):1639-40. PubMed ID: 11221592
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of aspirin resistance in type 2 diabetes.
    Singla MK; Lahiri P; Mukhopadhyay P; Pandit K; Chaudhuri U; Chowdhury S
    J Indian Med Assoc; 2008 Nov; 106(11):720, 722-3, 740. PubMed ID: 19368097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
    Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of aspirin on the antiproteinuric properties of enalapril in microalbuminuric type 2 diabetic patients: a randomized, double-blind, placebo-controlled study.
    Camargo EG; Weinert LS; Lavinsky J; Gross JL; Silveiro SP
    Diabetes Care; 2007 Jul; 30(7):e66. PubMed ID: 17596489
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of unresponsiveness to aspirin and/or clopidogrel in patients with stable coronary heart disease.
    Lordkipanidzé M; Diodati JG; Schampaert E; Palisaitis DA; Pharand C
    Am J Cardiol; 2009 Nov; 104(9):1189-93. PubMed ID: 19840560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vivo platelet aggregation in coronary disease and following administration of various drugs].
    Stolarska B; Skarzyńska M
    Pol Tyg Lek; 1977 Nov; 32(47):1829-31. PubMed ID: 600841
    [No Abstract]   [Full Text] [Related]  

  • 13. ACE inhibition and lateral thinking.
    Taylor RP
    Med J Aust; 1994 Jan; 160(2):92. PubMed ID: 8309376
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of dilazep on circulating platelet aggregation in diabetics].
    Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1832-7. PubMed ID: 6671042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease.
    Kim H; Lee HK; Han K; Jeon HK
    Ann Clin Lab Sci; 2009; 39(3):289-94. PubMed ID: 19667414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A contribution to the study of blood platelet aggregation].
    Pstruzinová H; Goderová Z; Kristan M
    Cas Lek Cesk; 1982 Nov; 121(47):1462-5. PubMed ID: 7151112
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspirin and coronary artery diseases.
    Jauhari J
    J Indian Med Assoc; 1993 Mar; 91(3):50-1. PubMed ID: 8349998
    [No Abstract]   [Full Text] [Related]  

  • 18. The presence of coronary artery disease increases platelet-dependent thrombosis in patients with type 2 diabetes mellitus.
    Natarajan A; Marshall SM; Worthley SG; Badimon JJ; Zaman AG
    J Thromb Haemost; 2008 Dec; 6(12):2210-3. PubMed ID: 18983525
    [No Abstract]   [Full Text] [Related]  

  • 19. [Imolamine in ischemic cardiopathy: results of a study of platelet aggregation in vitro and ex vivo].
    Tremoli E; Maderna P; Cocuzza E; Camisasca E; Catenazzo G; Mantero O
    Clin Ter; 1980 Apr; 93(1):79-88. PubMed ID: 7449335
    [No Abstract]   [Full Text] [Related]  

  • 20. Optical aggregometry and aspirin resistance.
    Feher G; Pusch G; Szapary L
    Acta Neurol Scand; 2009 Feb; 119(2):139; author reply 140. PubMed ID: 18647274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.